title: Monoclonal gammopathy of undetermined significance and anti-TNF-α treatment: comments on the article by Smale and Lawson.
authors.affiliation: Section for Rheumatology, Department of Neurology, Rheumatology, and Physical Medicine, Førde, Norway.
authors.forename: P
authors.initials: P
authors.lastname: Mielnik
authors.forename: A M
authors.initials: AM
authors.lastname: Hjelle
authors.forename: D
authors.initials: D
authors.lastname: Szatkowski
mesh_terms: D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D018501:Antirheumatic Agents / Q000009:adverse effects*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D006801:Humans; D008297:Male; D010265:Paraproteinemias / Q000139:chemically induced*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
chemical_list: D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D014409:Tumor Necrosis Factor-alpha